Актуальность

Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, gave a speech at a conference held in Poland on treating patients with poor ovarian response and personalising courses of treatment.

‘IB International Workshop 2018: A new approach to nursing in fertility’ is the international congress due to be held on 11^th and 12^th May in the Instituto Bernabeu auditorium, Alicante. The event will bring together professionals from the field of nursing and experts in caring for reproductive medicine patients and, in doing so, share and explore knowledge that improves global care for these patients.

Instituto Bernabeu has been awarded the Whereivf.com international platform annual IVF PGD/PGS prize. Whereivf.com is the largest international directory of assisted reproduction clinics and the prize is awarded to clinics that stand out in complexity, innovation and efficiency to the benefit of its patients.

Under the headline ‘They are science’, the specialist healthcare magazine, Diario Sanitario, has selected Dr María Antonia López Rubio, a gynaecologist at Instituto Bernabeu in Albacete, Spain, to form part of an article on the role of women in the field of science. The publication highlights the work of female researchers in the Castilla La Mancha autonomous community. It presents the Instituto Bernabeu gynaecologist and cum laude Doctor of Medicine from the Autonomous University of Madrid as an example of hard work and perseverance. The aim of the publication is to shed light on the role of women in science. At Instituto Bernabeu, 80% of the team is female and over half over the management positions are the responsibility of female employees.

Children between 5 and 12 years of age can participate in one of two categories - one for children aged 5 to 8 years and another for children aged 9 to 12 years.

Instituto Bernabeu has embarked on a collaboration agreement with the Faculty of Medicine at the Complutense University of Madrid (UCM) so that students from one of the university’s courses can do work experience at the clinic located in Calle Ayala 48, Madrid.

The new Instituto Bernabeu Group newsletter is now available. Instituto Bernabeu has opened an elite reproductive medicine clinic in the heart of the Salamanca neighbourhood in Madrid's city centre.

The Instituto Bernabeu clinic will participate in a refresher course on reproductive medicine further to invitation by the Vall d’Hebrón Hospital which is organising an event for experts in the field in order to cover latest progress in obstetrics and reproduction.

Doctor Pino Navarro, an endocrinologist at the Instituto Bernabeu, has received institutional recognition from the Regional Government of Valencia for her research centred on women entitled “Diagnostic criteria of gestational diabetes. An update?”.

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Rafael Bernabeu Charitable Foundation opens the Fifth call for its scholarships for university students endowed with 45.000 euros. Students of Medicine, Nursing, Biology and Biotechnology of Universities from all over the country, that have brilliant trajectories and whose family income is an obstacle to continue their studies.

The Rafael Bernabeu Foundation has launched the fifth edition of its €45,000 university student scholarship programme.

Genetics tests carried out prior to conception mean that children can now be born free of certain illnesses. Molecular biology experts in the Instituto Bernabeu Genetics Department at IB Biotech will enable couples to have children who are free of health conditions thanks to the most groundbreaking techniques using the very latest technology. 

Instituto Bernabeu research presented at the 9^th edition of the Congress of the Society for the Study of Reproduction Biology (ASEBIR) held in Madrid found that the natural antioxidant cinnamtannin B1 present mainly in bay leaves and cinnamon protects spermatozoa from DNA damage. This natural protector increases the ability to fertilise the ovum and improves the quality of the embryos that are generated.

At the Association for the Study of Reproduction Biology (ASEBIR)'s 9th Congress held in Madrid, Instituto Bernabeu introduced a research paper focusing on checking the MLPA (Multiplex Ligation-dependent Probe Amplification) technique's sensitivity levels in order to find out how specific alterations can affect sperm production. Our investigation entitled: "New technique to detect Y chromosome microdeletion (YCM): Clinical implications” was based on the fact that Y chromosomes comprise different genetic regions involved with spermatogenesis or sperm production. In the event that one of these regions, also known as AZF, was deleted or duplicated, this could result in either a low amount or the complete absence of sperm.

The aim of the study led by Instituto Bernabeu gynaecologist, Francisco Sellers, and endorsed by the Association for the Study of Reproduction Biology (ASEBIR), was to determine if there are differences between the quantity of trophoblastic vascularisation during early stages of spontaneous pregnancies and pregnancies after assisted reproduction techniques (ART).

Instituto Bernabeu presented research work in poster format at the 9^th edition of the Congress of the Association for the Study of Reproduction Biology (Asebir) held in Madrid in November. The research is based on data obtained from observing if there is a relationship between the morphological characteristics of an embryo, in accordance with Asebir criteria, and the presence of mosaicism in blastocyst biopsies.

Instituto Bernabeu has presented research work entitled 'Is there a relationship between oocyte retrieval and maturation, and embryo aneuploidy and mosaicism rates?' at the 9^th edition of the Congress of the Association for the Study of Reproduction Biology (ASEBIR). The research focuses on the relationship between the number of oocytes retrieved and matured following ovarian puncture and rates of embryo aneuploidy and mosaicism (chromosomal and cellular abnormalities).

The new Instituto Bernabeu Group newsletter is now available. Andrea Bernabeu, PhD, MD, Gynaecologist at Instituto Bernabeu, has received in New York the Young Investigator Award for her work on advanced genetics techniques on chromosome alteration on embryos.  

Dr Belén Lledó, a molecular biologist at Instituto Bernabeu, has participated in an international gathering of experts in reproductive medicine genetic technologies held in Paris. The gathering included events covering the very latest in the field from both a technical and ethical point of view.

Instituto Bernabeu Group's commitment to the most demanding of quality levels has once again been reflected in a further annual renewal of the Quality Healthcare (QH) official certification for excellence in healthcare that is awarded by the Institute for Development and Integration of Healthcare (IDIS from the Spanish acronym).

Instituto Bernabeu has delivered research work on the detection of chromosomal mosaicism in embryos using next generation sequencing (NGS) and its influence on birth rates to the Association for the Study of Reproduction Biology (ASEBIR) congress to be held in Madrid. Thanks to this complex technique, the researchers have proven that low-grade mosaicism in the embryo does not affect the birth of healthy children to a significant degree.

Instituto Bernabeu is responsible for organising the 'IB International Workshop 2018: A new approach to nursing in fertility' international congress due to be held on 11^th and 12^th May 2018 in the auditorium at the clinic's headquarters in Alicante. The aim is to bring together professionals from the field of nursing and experts in caring for reproductive medicine patients and, in doing so, share and delve deep into knowledge that improves global care specifically for these patients.

On Friday 24^th November, Dr María Antonio López Rubio, a gynaecologist at Instituto Bernabeu in Albacete, will participate in the 22^st edition of the event organised by the Spanish Society of General Practitioners of Castilla La Mancha that is due to be held in Cuenca between 23^rd and 25^th November. 

Andrea Bernabeu, PhD, MD, Gynaecologist at Instituto Bernabeu, has received in New York the Young Investigator Award for her work on advanced genetics techniques on chromosome alteration on embryos. 

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Instituto Bernabeu deals with the most complex of cases because it has over 30 years' experience that are a guarantee of expert hands at a leading clinic where each case is given personalised treatment. Wasting time is not an option when we are racing against the clock. When the aim of that race is a pregnancy, it is impossible to recover missed opportunities. If a woman's age and the fact that she is not getting pregnant combine, there is only one possible piece of advice: Put yourself in the very best hands and do not leave what quality reproductive medicine can do for you to chance.

On 24^th November, the University of Alicante will hold the V Edition of Patent Rights and Biotechnology Event organised by Magister Lvcentinvs - the centre for Master's Degree education in Industrial and Intellectual Property at the University of Alicante.  At the event, university lecturers, lawyers and other experts in the field of biotechnology will cover specific aspects of the legal impact of scientific progress.

A team of researchers at Instituto Bernabeu has completed a prospective randomised clinical trial aimed at understanding if selection of an embryo generated during a cycle of in vitro fertilisation (IVF) is possible when morphological development is observed just once over the days leading up to transfer. The results of the research work will be presented at the national congress organised by the Association for the Study of Reproduction Biology due to be held in Madrid between 15^th and 17^th November.

Instituto Bernabeu will once again participate in the Association for the Study of Reproduction Biology (ASEBIR) Congress that is due to be held in Madrid between 15^th and 17^th November. The reproductive medicine clinic will present ten pieces of research work at the congress. Four of these were produced by the Embryology Unit at Instituto Bernabeu; another by the Egg Donation Unit; and the remaining pieces of work were carried out by the clinic's Molecular Biology and Genetics departments. 

The Medical Director of Instituto Bernabeu, Dr Rafael Bernabeu, will participate in the 5^th edition of the Contraception Congress organised by the Castilla La Mancha Contraception Society due to be held in Albacete on the 10^th and 11^th November. The Director of the Instituto Bernabeu Group, Dr Rafael Bernabeu, will cover the revolutionary discovery of the uses of anti-mullerian hormone in his speech entitled 'A new paradigm in contraception: AMH and derivatives.'

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Within the framework of annual support given to university studies, the Rafael Bernabeu Social Welfare Foundation at Instituto Bernabeu has awarded scholarships to six Medicine and Nursing university students. The scholarships have a value of 2,500 euros each.

Instituto Bernabeu will present a study entitled 'Embryo mosaicism and its impact on the results of cycles of in vitro fertilisation (IVF) and associated factors' at the 19^th edition of the Congress of the Association for the Study of Reproduction Biology (ASEBIR) due to be held in Madrid between 15^th and 17^th November.

The clinic has promoted a scientific exchange in which prominent specialists from the Region of Murcia participate in a conference that takes place at the Universidad Politécnica of Cartagena on Friday 1^st December.

Instituto Bernabeu will present one of its lines of research work in North America. It will do so at the American Society of Reproductive Medicine Congress (ASRM) due to be held between 28^th October and 1^st November in San Antonio and the research consists of a clinical trial for improving patient comfort during assisted reproduction treatment. 

A multidisciplinary team of professionals from Instituto Bernabeu, including Gynaecologists, Biologists, Geneticists, Pharmacists and Embryologists, participates as speakers at the opening of the IV Course on Stem Cells and Clinical Human Embryology, taking place on the 27^th October. This is a theoretical-practical course organized by the Biotechnology Department of the University of Alicante.

Within the framework of annual support given to university studies, the Rafael Bernabeu Social Welfare Foundation at Instituto Bernabeu has awarded scholarships to six Medicine and Nursing university students.

Pharmacy Faculty students are today, Thursday 27^th October, participating in an embryology workshop being held at Instituto Bernabeu in Alicante as part of the XIII edition of the Congress of Pharmacy Students organised by the Miguel Hernández University at its San Juan campus.

The Bar Association of Madrid requested the intervention of expert geneticists from Instituto Bernabeu in its event on paternity tests, a gathering of scientists and lawyers held on 23^rd October at the bar association's headquarters.

The Instituto Bernabeu is helping out once again this year in the University Master’s on Community Pharmacy Direction and Management & Optimization of Pharmaceutical Care organised by the Universidad Miguel Hernández (UMH). Doctor Andrea Bernabeu has taken part in this fourth edition that deals with aspects related to pregnancy and maternal-child health with theoretical and practical classes.

The Instituto Bernabeu and the Chair of Reproductive Medicine of Alicante University (UA) have presented a research project related to smoking and fertility at the 19^th Congress of the Spanish Society of Histology and Tissue Engineering, the 4^th Ibero-American Congress of Histology and the 7^th International Congress of Histology and Tissue Engineering held in Santiago de Compostela.

Advanced maternal age is the main factor associated with chromosome abnormalities or aneuploidies in the embryo, which cause problems during the pregnancy and increase the risk of miscarriage. 

Together with the Association of Pharmacists of Albacete, Instituto Bernabeu is organising the Pharmacotherapy in Reproductive Medicine course due to be held in the association's conference hall in Albacete. The four-day course will be held on 17^th October, 24^th October, 7^th November and 14^th November. 

At the 9^th edition of the Association for the Study of Reproduction Biology (ASEBIR) Congress to be held in Madrid between 15^th and 17^th November, Instituto Bernabeu will present the results obtained when evaluating a new means of administering drugs during ovarian stimulation that reduces the number of injections required. 

Sensitive to social causes for years, Instituto Bernabeu has been involved one more year in the awareness month of Breast Cancer. Under the title, "Feel that you love me" Instituto Bernabeu Foundation organizes a day, Tuesday 24th October, to address gynaecological cancer with patient’s testimonies and experts opinions.

Specialists from the Embryology Unit at Instituto Bernabeu will present research work entitled 'Conventional IVF improves the results of an egg donation programme compared with the use of ICSI' at the 9^th edition of the Association for the Study of Reproduction Biology (ASEBIR) Congress to be held in Madrid between 15^th and 17^th November. 

We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". In this occasion, to inform you about the Genetic Compatibility Test carried out at Instituto Bernabeu, that allows to detect more than 600 hereditary diseases that we can pass on to our future children.

The new Instituto Bernabeu Group newsletter is now available, dedicated to our last reserach work accepted at congress ESHRE 2017.

For the sixth year in a row, Instituto Bernabeu (IB) and the University of Alicante (UA), through the Reproductive Medicine Professorship, are organising a Master's Course in Reproductive Medicine. 

As a part of our continuous training programme, an intensive theoretical and practical seminar entitled ‘Advanced Workshop in Embryo Biopsy: Techniques and tips for usage’ will take place next September. The workshop is aimed at reproduction biologists who are specialised in micro-handling techniques.

The researchers look at the selection that can be made of chromosomally normal embryos with preimplantation genetic screening (PGS) by using the next-generation sequencing (NGS) technique. This leads to an improvement in the results of in-vitro fertilization (IVF) since it detects chromosomally normal embryos, those which are abnormal and also those known as mosaic, which have both normal and abnormal cells. In the case of mosaic embryos, studies show that the abnormal cells are replaced with normal cells and that they may be implanted and are able to develop into a healthy child, although the success rate is somewhat lower.

The Instituto Bernabeu presents a study on the prevention of DNA fragmentation of sperm, thanks to natural antioxidants, at the international meeting of specialists in reproductive medicine organized by the European Society of Human Reproduction and Embryology (ESHRE).

Researchers of the Instituto Bernabeu present a study at the meeting of the European Society of Human Reproduction and Embryology (ESHRE), held in Switzerland from 2 to 5 July, in which new techniques are applied to enable more precise detection of sperm production.

The research by the Instituto Bernabeu studies the influence of cytokines, molecules that mediate in immune response with consequences such as inflammation, and which would enable early detection of endometriosis.

Instituto Bernabeu in Albacete and Alicante (IB), in collaboration with the University of Castilla-La Mancha (UCLM) are organising the second edition of the Master's Course in Male Infertility. 

New issue of Instituto Bernabeu corporate newsletter (IB NEWSLETTER). Our fertility and gynaecology clinic in Benidorm is under renovation, with new facilities and cutting edge technology in order to maintain our high quality, personalised service.

A study by the Instituto Bernabeu has found a correlation between embryo quality and a greater probability of the appearance of mosaicism, the presence of normal cells together with other abnormal cells. For some time, the Instituto Bernabeu has followed different lines of research related to embryo mosaicism and its detection, since these embryos may have lower implantation rates and a greater risk of aneuploidy, a chromosomal abnormality that may lead to genetic disorders.

At Instituto Bernabeu, we are an innovative medical centre which applies the latest, cutting edge technologies and techniques to improve our patient's living standards.

Dr. Joaquin Llacer, associate director at Instituto Bernabeu, has been elected to represent all Spanish specialist doctors at the European Society of Human Reproduction and Embryology.

Everything is changing in order to ensure that all remains the same. That is, offering a personalised treatment to every patient attending Instituto Bernabeu.

A study by the Instituto Bernabeu selected by the committee of experts of the international meeting of the European Society of Human Reproduction and Embryology, held from 2 to 5 July in Geneva, finds a correlation between the manner in which embryo division takes place and the future chromosome count of the embryo. 

New issue of Instituto Bernabeu corporate newsletter (IB NEWSLETTER). Instituto Bernabeu leads the new research for the treatment of implantation failure of the embryo and its link with recurrent miscarriage. One of these lines of work is focused on the personalization of the treatment to the specific response of each patient.